LABORIE’s Portascan™ 3D received Innovative Technology Designation from Vizient, Inc. the largest member-driven health care performance improvement company in the country. Innovation Technology Designation recognizes products that bring improvements to the health care industry. The designation was based on reviews of Portascan 3D by hospital experts who attended Vizient’s Innovative Technology Exchange in September 2016.
The event provided medical technology suppliers the opportunity to demonstrate their product and gain direct feedback from 1300 onsite clinical experts and health care providers on the impact their products may have on improving clinical care, safety, or benefits to an organization’s care and business model.
Portascan 3D is an advanced 3D automatic bladder scanner with live pre-scan functionality and does not require annual calibration. With live ultrasound functionality it allows the user to quickly find the bladder so the Portascan 3D can accurately calculate the bladder volume. Portascan 3D provides reliable information, thus reducing the frequency of catheterization and risk of UTIs (CAUTI). It is also a valuable tool for providing post-void residual volume (PVR) to assess possible urinary retention.
Portascan 3D Features & Benefits:
“We are honored to be given this prestigious designation from Vizient,” stated Ing Goping, LABORIE’s Chief Scientific Officer. “LABORIE has been dedicated to the development and delivery of innovative diagnostic solutions for almost 50 years. We recognize the need to offer progressive solutions to ensure better patient outcomes.”
“With a high number of products and services being released and marketed as ‘innovative’, our member hospitals truly value the peer-review system in place at Vizient to help them identify products worth further evaluation at their own facilities,” said Debbie Archer, director of procurement and leader of Vizient’s Innovative Technology program for suppliers. “After a review of the Portascan 3D, Vizient’s members agreed this product offers unique and incremental benefit over other products available on the market today, and recommended it for an Innovative Technology designation.”
Vizient, Inc. represents the combined strengths of the organizations formerly known as VHA Inc., University HealthSystem Consortium, Novation and MedAssets’ Spend and Clinical Resource Management. Since 2003, nearly 2200 new and innovative products and technologies have been submitted through the Vizient Innovative Technology program. Vizient works with member-led councils and task forces to identify and review potentially innovative products. If it is determined that a product is innovative, a contract may be awarded outside of Vizient’s competitive bid cycle.
LABORIE is an industry-leading manufacturer and supplier of pelvic health and gastrointestinal equipment and consumables. Since its founding in 1967, LABORIE has been committed to delivering innovative, complete solutions that provide better diagnostics and treatment outcomes to patients worldwide.
LABORIE Medical Technologies (“LABORIE”) and Cogentix Medical, Inc. (NASDAQ: CGNT) (“Cogentix”) today announced the completion of the acquisition by LABORIE of Cogentix through LABORIE’S affiliate Camden Merger Sub, Inc. (“Merger Sub”), a wholly owned subsidiary of LM US Parent, Inc. (“Parent”).
LABORIE Medical Technologies (“LABORIE”) announced the successful completion of the tender offer by its affiliate Camden Merger Sub, Inc. (“Merger Sub”), a wholly owned subsidiary of LM US Parent, Inc. (“Parent”) to purchase all outstanding shares of common stock of Cogentix Medical, Inc. (NASDAQ: CGNT) (“Cogentix”)
LABORIE Medical Technologies, a leading global developer and manufacturer of medical diagnostics and devices in the pelvic health and gastroenterology market, today announces the execution of a definitive agreement to acquire Cogentix Medical Inc., (NASDAQ: CGNT)